N.J. Admin. Code § 10:56-2.22 - Medical exception process (MEP)
(a) For
pharmacy claims with service dates on or after September 1, 1999, which exceed
PDUR standards recommended by the New Jersey DUR Board and approved by the
Commissioners of DHS and DHSS, the Division of Medical Assistance and Health
Services has established a Medical Exception Process (MEP).
(b) The medical exception process (MEP) shall
be administered by a contractor, referred to as the MEP contractor, under
contract with the Department of Human Services.
(c) The medical exception process shall apply
to all pharmacy claims, regardless of claim media, unless there is a
recommended exemption by the New Jersey DUR Board which has been approved by
the Commissioners of DHS and DHSS, in accordance with the rules of those
Departments.
(d) The medical
exception process (MEP) is as follows:
1. The
MEP contractor shall contact prescribers of conflicting drug therapies, or drug
therapies which exceed established PDUR standards, to request written
justification to determine medical necessity for continued drug utilization.
i. The MEP contractor shall send a Prescriber
Notification Letter which includes, but may not be limited to, the beneficiary
name, HSP identification number, dispense date, drug quantity, drug
description. The prescriber shall be requested to provide the reason for
medical exception, diagnosis, expected duration of therapy, and expiration date
for medical exception.
ii. The
prescriber shall provide information requested on the Prescriber Notification
to the MEP contractor.
2. Following review and approval of a
prescriber's written justification, if appropriate, the MEP contractor shall
override existing PDUR edits through the issuance of a prior authorization
number.
3. The MEP contractor shall
notify the pharmacy and prescriber of the results of their review and include
at a minimum, the beneficiary's name, mailing address, HSP number, the
reviewer, service description, service date, and prior authorization number, if
approved, the length of the approval and the appeals process if the pharmacist
does not agree with the results of the review.
4. Prescribers may request a fair hearing to
appeal decisions rendered by the MEP contractor concerning denied claims (see
N.J.A.C. 10:49-10, Notices, Appeals and Fair Hearings).
Notes
See: 31 N.J.R. 245(a), 31 N.J.R. 1956(a).
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.